What is the market cap of Indegene Limited?

As of 31/08/2026, the market cap of Indegene Limited stands at ₹14,736.20 Cr.

What is the PE and PB ratio of Indegene Limited?

The PE and PB ratios of Indegene Limited is 61.49 ratio and 86.34 ratio as of 31/08/2026.

What is the 52 week high and low of Indegene Limited?

The 52 week high and low of Indegene Limited is ₹615.5 and ₹414 as of 31/08/2026.

How can I buy Indegene Limited share?

You can easily buy Indegene Limited shares on the Bajaj Broking platform by opening a Demat account and verifying your KYC documents online. There are no account opening charges for a Demat account with Bajaj Broking.

What determines a company’s share price?

A company’s share price is determined by supply and demand dynamics in the stock market. Factors influencing it include the company’s financial performance, earnings growth, revenue, and profitability, as well as broader economic conditions, market sentiment, and investor perception. Other determinants include sector trends, government policies, interest rates, and global events. Positive news or growth prospects can drive demand and raise the share price, while negative developments can push it lower. Analysts’ recommendations, institutional buying or selling, and technical factors such as trading volume also influence price movements. Ultimately, the share price reflects the market’s collective view of a company’s current and future value.

What is the “last sale,” “bid,” and “ask” price of Indegene Limited?

The “last sale” is the most recent price at which a stock, like Indegene Limited , was traded. The “bid” price represents the highest price buyers are willing to pay, while the “ask” price is the lowest price sellers are ready to accept. The difference between the bid and ask is known as the spread. Monitoring these prices helps investors understand market sentiment and liquidity. For example, a narrow spread indicates high liquidity and active trading, while a wide spread may suggest lower activity or higher volatility. These metrics are crucial for executing timely buy or sell orders in the stock market.

How to read share price charts for Indegene Limited?

Share price charts display the historical price movement of Indegene Limited , helping investors analyse trends, patterns, and potential entry or exit points. Charts typically show candlestick patterns, line graphs, or bar charts, representing open, high, low, and close prices. Key indicators include moving averages, support and resistance levels, and trading volume. Candlestick patterns can reveal bullish or bearish trends, while volume confirms the strength of price movements. Investors can use charts for technical analysis to assess momentum, predict short-term fluctuations, or complement fundamental analysis for long-term decisions. Understanding trends over daily, weekly, or monthly periods helps in making informed trading and investment choices.

What is volatility, and how does it affect share price movement for Indegene Limited?

Volatility measures the degree of price fluctuations of a stock over time. High volatility indicates that Indegene Limited share price can experience large swings in short periods, while low volatility suggests stable prices. Factors causing volatility include market sentiment, earnings announcements, global events, economic indicators, and industry news. High volatility can create opportunities for traders to profit from rapid price changes but also increases risk for long-term investors. Understanding volatility helps investors manage risk, set stop-loss limits, and determine the appropriate investment horizon based on their risk tolerance.

INDEGENE LIMITED Share price

INDGN

Small Cap | Healthcare

₹611.65

+32.7 (+5.64%)

‌

Stock price as on 31 Aug 2026 at 15:30 PM

Indegene limited share price today

As of the latest trading session, Indegene Limited share price is currently at ₹611.65, which is up by ₹32.7 from its previous closing. Today the stoc...

Indegene Limited stock performance

Today’s low

₹579.85

Today’s high

₹615.5

₹611.65

52 week low

₹414

52 week high

₹615.5

₹611.65

Open

₹582.10

Previous close

₹578.95

Share volume

39,72,278

Total traded value (Lakh)

₹24,296.43

Upper circuit

₹694.70

Lower circuit

₹463.20

Indegene Limited fundamentals

Market cap (Cr)

₹14,736.20

P/E ratio (TTM)

61.49

Book value per share

₹86.34

Beta

0.82

Return on equity

10.68%

Earnings per share (TTM)

₹9.41

Dividend yield

0.39%

Net profit/quarter (Cr)

₹59.90

Indegene Limited financials

(Values in Cr)

Revenue

Net income

Particulars	Jun 26 (₹ value in crores)
Revenue	₹340.70
Operating expense	₹294.59
Net income	₹59.90
Net profit margin	17.58%
Earning per share	₹2.49
EBITDA	₹94.10
Effective tax rate	25.12%

Particulars	Mar 26 (₹ value in crores)
Revenue	₹368.20
Operating expense	₹279.10
Net income	₹72.10
Net profit margin	19.58%
Earning per share	₹3.00
EBITDA	₹109.20
Effective tax rate	24.26%

Particulars	Dec 25 (₹ value in crores)
Revenue	₹290.10
Operating expense	₹263.70
Net income	₹34.80
Net profit margin	11.99%
Earning per share	₹1.45
EBITDA	₹60.30
Effective tax rate	28.97%

Particulars	Sep 25 (₹ value in crores)
Revenue	₹306.70
Operating expense	₹246.70
Net income	₹59.90
Net profit margin	19.53%
Earning per share	₹2.50
EBITDA	₹88.10
Effective tax rate	22.7%

Particulars	Jun 25 (₹ value in crores)
Revenue	₹255.60
Operating expense	₹227.89
Net income	₹45.10
Net profit margin	17.64%
Earning per share	₹1.88
EBITDA	₹68.80
Effective tax rate	24.58%

Particulars	Mar 26 (₹ value in crores)
Revenue	₹1,220.60
Operating expense	₹1,017.50
Net income	₹211.90
Net profit margin	17.36%
Earning per share	₹8.83
EBITDA	₹326.40
Effective tax rate	24.69%

Particulars	Mar 25 (₹ value in crores)
Revenue	₹1,093.60
Operating expense	₹945.50
Net income	₹181.30
Net profit margin	16.57%
Earning per share	₹7.64
EBITDA	₹270.90
Effective tax rate	23.98%

Particulars	Mar 24 (₹ value in crores)
Revenue	₹1,045.60
Operating expense	₹915.30
Net income	₹137.90
Net profit margin	13.18%
Earning per share	₹6.22
EBITDA	₹218.29
Effective tax rate	23.64%

Particulars	Mar 23 (₹ value in crores)
Revenue	₹1,005.70
Operating expense	₹865.90
Net income	₹130.20
Net profit margin	12.94%
Earning per share	₹5.89
EBITDA	₹214.70
Effective tax rate	26.27%

Particulars	Mar 22 (₹ value in crores)
Revenue	₹836.70
Operating expense	₹694.60
Net income	₹132.70
Net profit margin	15.85%
Earning per share	₹758.28
EBITDA	₹196.50
Effective tax rate	21.89%

Particulars (annual)	Mar 26 (₹ value in crores)
Book value per share	₹130.49
Return on Equity (ROE)	13.94%
Return on Capital Employed (ROCE)	17.11%
Total debt to equity ratio	0.04
EBITDA margin	19.11%

Particulars (annual)	Mar 25 (₹ value in crores)
Book value per share	₹109.17
Return on Equity (ROE)	20.11%
Return on Capital Employed (ROCE)	23.31%
Total debt to equity ratio	0.15
EBITDA margin	22.59%

Particulars (annual)	Mar 24 (₹ value in crores)
Book value per share	₹64.37
Return on Equity (ROE)	27.01%
Return on Capital Employed (ROCE)	27%
Total debt to equity ratio	0.4
EBITDA margin	22.56%

Particulars (annual)	Mar 23 (₹ value in crores)
Book value per share	₹48.03
Return on Equity (ROE)	29.12%
Return on Capital Employed (ROCE)	29.51%
Total debt to equity ratio	0.31
EBITDA margin	19.69%

Particulars (annual)	Mar 22 (₹ value in crores)
Book value per share	₹4,352.71
Return on Equity (ROE)	34.93%
Return on Capital Employed (ROCE)	41.6%
Total debt to equity ratio	0.11
EBITDA margin	18.79%

Particulars (annual)	Mar 26 (₹ value in crores)
Book value per share	₹86.49
Return on Equity (ROE)	10.68%
Return on Capital Employed (ROCE)	13.8%
Total debt to equity ratio	0.02
EBITDA margin	26.74%

Particulars (annual)	Mar 25 (₹ value in crores)
Book value per share	₹78.80
Return on Equity (ROE)	12.76%
Return on Capital Employed (ROCE)	16.27%
Total debt to equity ratio	0.02
EBITDA margin	24.77%

Particulars (annual)	Mar 24 (₹ value in crores)
Book value per share	₹42.96
Return on Equity (ROE)	15.77%
Return on Capital Employed (ROCE)	19.54%
Total debt to equity ratio	0.05
EBITDA margin	20.88%

Particulars (annual)	Mar 23 (₹ value in crores)
Book value per share	₹35.91
Return on Equity (ROE)	18.02%
Return on Capital Employed (ROCE)	22.85%
Total debt to equity ratio	0.07
EBITDA margin	21.35%

Particulars (annual)	Mar 22 (₹ value in crores)
Book value per share	₹3,250.00
Return on Equity (ROE)	29.36%
Return on Capital Employed (ROCE)	34.22%
Total debt to equity ratio	0.07
EBITDA margin	23.49%

Particulars	Mar 26 (₹ value in crores)
Cash and short term investments	₹381.90
Total assets	₹4,620.30
Total liabilities	₹4,620.30
Total equity	₹3,138.70
Shares outstanding	₹24.05
Price to book ratio	₹5.02
Return on assets (%)	8.68%
Return on capital	12.78%

Particulars	Mar 25 (₹ value in crores)
Cash and short term investments	₹374.60
Total assets	₹3,325.90
Total liabilities	₹3,325.90
Total equity	₹2,615.60
Shares outstanding	₹23.96
Price to book ratio	₹7.34
Return on assets (%)	12.22%
Return on capital	15.55%

Particulars	Mar 24 (₹ value in crores)
Cash and short term investments	₹191.00
Total assets	₹2,545.60
Total liabilities	₹2,545.60
Total equity	₹1,429.10
Shares outstanding	₹22.20
Price to book ratio	-
Return on assets (%)	13.22%
Return on capital	18.38%

Particulars	Mar 23 (₹ value in crores)
Cash and short term investments	₹85.80
Total assets	₹2,203.90
Total liabilities	₹2,203.90
Total equity	₹1,063.80
Shares outstanding	₹22.14
Price to book ratio	-
Return on assets (%)	12.07%
Return on capital	18.25%

Particulars	Mar 22 (₹ value in crores)
Cash and short term investments	₹517.30
Total assets	₹1,353.46
Total liabilities	₹1,353.46
Total equity	₹763.90
Shares outstanding	₹0.17
Price to book ratio	-
Return on assets (%)	12.17%
Return on capital	21.07%

Particulars	Mar 26 (₹ value in crores)
Cash and short term investments	₹129.60
Total assets	₹2,481.90
Total liabilities	₹2,481.90
Total equity	₹2,080.50
Shares outstanding	₹24.05
Price to book ratio	₹5.02
Return on assets (%)	8.53%
Return on capital	10.19%

Particulars	Mar 25 (₹ value in crores)
Cash and short term investments	₹163.60
Total assets	₹2,149.70
Total liabilities	₹2,149.70
Total equity	₹1,888.20
Shares outstanding	₹23.96
Price to book ratio	₹7.34
Return on assets (%)	8.43%
Return on capital	9.6%

Particulars	Mar 24 (₹ value in crores)
Cash and short term investments	₹15.60
Total assets	₹1,220.30
Total liabilities	₹1,220.30
Total equity	₹953.80
Shares outstanding	₹22.20
Price to book ratio	-
Return on assets (%)	11.3%
Return on capital	14.46%

Particulars	Mar 23 (₹ value in crores)
Cash and short term investments	₹54.00
Total assets	₹1,037.70
Total liabilities	₹1,037.70
Total equity	₹795.30
Shares outstanding	₹22.14
Price to book ratio	-
Return on assets (%)	12.54%
Return on capital	16.37%

Particulars	Mar 22 (₹ value in crores)
Cash and short term investments	₹38.80
Total assets	₹850.10
Total liabilities	₹850.10
Total equity	₹650.00
Shares outstanding	₹0.17
Price to book ratio	-
Return on assets (%)	15.6%
Return on capital	20.42%

Particulars	Mar 26 (₹ value in crores)
Net income	₹525.00
Cash from operations	₹798.40
Cash from investing	-₹512.40
Cash from financing	-₹82.60
Net change in cash	₹55.80
Free cash flow	₹842.69

Particulars	Mar 25 (₹ value in crores)
Net income	₹539.30
Cash from operations	₹601.90
Cash from investing	-₹682.70
Cash from financing	₹287.50
Net change in cash	₹46.70
Free cash flow	₹631.90

Particulars	Mar 24 (₹ value in crores)
Net income	₹458.60
Cash from operations	₹632.60
Cash from investing	-₹327.20
Cash from financing	-₹66.20
Net change in cash	₹114.30
Free cash flow	₹643.30

Particulars	Mar 23 (₹ value in crores)
Net income	₹363.00
Cash from operations	₹238.40
Cash from investing	-₹893.30
Cash from financing	₹333.10
Net change in cash	-₹430.00
Free cash flow	₹257.20

Particulars	Mar 22 (₹ value in crores)
Net income	₹226.49
Cash from operations	₹367.38
Cash from investing	-₹160.20
Cash from financing	₹233.47
Net change in cash	₹370.31
Free cash flow	₹392.09

Particulars	Mar 26 (₹ value in crores)
Net income	₹281.40
Cash from operations	₹393.50
Cash from investing	-₹272.10
Cash from financing	-₹62.60
Net change in cash	₹10.90
Free cash flow	₹437.60

Particulars	Mar 25 (₹ value in crores)
Net income	₹238.50
Cash from operations	₹199.60
Cash from investing	-₹824.70
Cash from financing	₹717.30
Net change in cash	₹21.60
Free cash flow	₹216.10

Particulars	Mar 24 (₹ value in crores)
Net income	₹180.60
Cash from operations	₹225.50
Cash from investing	-₹187.70
Cash from financing	-₹15.80
Net change in cash	-₹27.30
Free cash flow	₹235.40

Particulars	Mar 23 (₹ value in crores)
Net income	₹176.60
Cash from operations	₹123.70
Cash from investing	-₹47.90
Cash from financing	-₹16.90
Net change in cash	₹17.10
Free cash flow	₹139.50

Particulars	Mar 22 (₹ value in crores)
Net income	₹169.90
Cash from operations	₹74.10
Cash from investing	-₹266.70
Cash from financing	₹244.90
Net change in cash	₹16.40
Free cash flow	₹95.10

Company name	Price	P/E	P/B	Market cap	52 week low/high
APOLLO HOSPITALS ENTER. L	₹8,845.70	60.45	13.41	₹1,27,187.59	₹6,680.00 / ₹9,326.80
FORTIS MALAR HOSPITALS LIMITED	₹46.02	0	2.51	₹86.25	₹40.75 / ₹76.00
SHREE PACETRONIX LTD.	₹139.00	16.11	2.92	₹52.12	₹90.00 / ₹283.15
TRANSGENE BIOTEK LTD.	₹2.90	0	2.62	₹21.97	₹1.83 / ₹4.50

Company name	Price	P/E	P/B	Market cap	52 week low/high
APOLLO HOSPITALS ENTER. L	₹8,845.70	60.45	13.41	₹1,27,187.59	₹6,680.00 / ₹9,326.80
FORTIS MALAR HOSPITALS LIMITED	₹46.02	0	2.51	₹86.25	₹40.75 / ₹76.00
SHREE PACETRONIX LTD.	₹139.00	16.11	2.92	₹52.12	₹90.00 / ₹283.15
TRANSGENE BIOTEK LTD.	₹2.90	0	2.62	₹21.97	₹1.83 / ₹4.50

Indegene Limited technical summary

₹611.65

+ 5.64 ▲

Bearish

Bullish

5 Day570.9

10 Day567.2

12 Day565.5

20 Day558.1

26 Day553.1

50 Day539.2

100 Day525.4

200 Day523.8

Investment Returns

Over 1 Month13.85%▲

Over 3 Months11%▲

Over 6 Months20.62%▲

Over 1 Year4.65%▲

Indegene Limited Shareholding pattern

Public

81.34%

Promoter holdings

FII

9.91%

DII

8.74%

Promoter shares

Promoter shares	Share	Category
Nadathur Fareast Pte Ltd	5,27,00,256 (21.87%)	Public Shareholding
Manish Gupta	2,14,74,076 (8.91%)	Public Shareholding
Rajesh Bhaskaran Nair	1,72,01,536 (7.14%)	Public Shareholding
Bpc Genesis Fund I Spv Ltd	1,38,62,223 (5.75%)	Public Shareholding
Sanjay S Parikh	1,20,08,172 (4.98%)	Public Shareholding

About INDEGENE LIMITED

Indegene Limited was incorporated as Indegene Lifesystems Private Limited' at Ahmedabad, Gujarat, as a Private Limited Company, dated October 16, 1998 at Ahmedabad. Subsequently, name of the Company was changed to Indegene Private Limited' and a fresh Certificate of Incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016. Thereafter, Company converted to a Public Company with change in name to Indegene Limited' on November 17, 2022. The Company is a digital-first life sciences commercialization company, enabling biopharmaceutical, emerging biotech, and medical device companies to develop, launch, and scale the impact of their products with greater speed and efficiency. As a specialized company, it combine healthcare domain expertise, fit-for-purpose technology, and an agile operating model to solve the most complex problems in the healthcare industry. Their Enterprise Commercial Solutions (ECS) involve assisting life sciences companies with their digital marketing operations. Omnichannel Activation solutions help life sciences companies leverage a 'digital first' approach for optimizing the last-mile promotion of biopharmaceutical products and medical devices to HCPs across multiple channels. Under Enterprise Medical Solutions, the Company establish centers of excellence (CoEs) to consolidate large scale regulatory and medical operations for their clients. Apart from these, the Company offer Enterprise Clinical Solutions and consultancy services, which help drive efficiencies in the drug discovery and clinical trial operations of life sciences companies. It bring in their expertise in data management and analytics in helping biopharmaceutical companies seamlessly handle and analyze multiple sources of data during clinical trials and build a case for regulatory approvals. In 2016, the Company acquired Encima Group, Inc. in the United States, a company which provided marketing analytics and campaign execution solutions to several large life sciences companies. In 2019, it acquired a minority stake in DT Associates Research and Consulting Services Limited, a digital transformation and client experience consulting firm in UK, to expand their strategic consulting capabilities. In December 2020, it acquired a majority stake in DT Associates Limited. On 8 December, 2021 the Company has demerged its commercial software business pursuant to a Scheme of Arrangement for transfer of the Demerged Business to OT Services India Private Limited (Resulting Company), approved by the National Company Law Tribunal, Bengaluru Bench with Appointed Date, i.e., October 1, 2020, which became effective on December 30, 2021. The Company acquired Cult Health, a full-service healthcare marketing agency for several life sciences brands, through its subsidiary, ILSL Holdings, Inc. on October 12, 2022. The Company launched Invisage, an AI-enabled hybrid omnichannel sales and marketing platform in 2023. The Company made a public issue of 40,766,550 Equity Shares of face value of Rs 2 each by raising funds aggregating to Rs. 1842 Crore comprising a fresh issue of 16,833,818 Equity Shares aggregating to Rs. 760 Crore and 23,932,732 Equity Shares aggregating to Rs 1082 Crore through Offer for Sale in May, 2024. In 2024, the Company acquired a controlling stake in Trilogy Writing & Consulting GmbH, a medical writing consultancy firm. It set up a new global delivery center in Hyderabad. In FY 2025, the Company launched a new center in Hyderabad to strengthen the business operations. In Europe, it launched a new entity in Spain and a new center in London. Indegene's Europe-based clients became as a strategic hub for consulting and commercialization solutions and modernize their operations with an AI-first approach. Further, the Company acquired MJL Life Sciences, a UK-based specialized healthcare advertising and communications agency. It launched Cortex, a fit-for-purpose Generative AI platform for the life sciences industry. In FY2025-26, Company acquired BioPharm in October 2025, acquired Warn & Co and Cake Kommunikations for global delivery in Europe.

Parent Organisation

Indian Private

NSE Symbol

INDGN

Founded

1998

INDEGENE LIMITED CORPORATE ACTION

Dividend date	Dividend amount	Dividend type	Record date	Instrument type
13 Jun 2025	2	Final	13 Jun 2025	Equity shares

View more stocks

apollo hospitals enter. l

₹8,898.5

▲ 0.67%

max healthcare institute limit

₹1,042.1

▲ 2.76%

manipal health enterprises lim

₹762.8

▼ 1.14%

fortis healthcare ltd.

₹906.9

▼ 2.14%

aster dm quality care limited

₹756

▲ 1.01%

global health limited

₹1,479.7

▲ 0.50%

narayana hrudayalaya ltd.

₹1,907.2

▼ 1.28%

What’s trending

All stocks

AIMCOPEST

AIMCO PESTICIDES LTD.

21474180

+21474132.22 (+44943767.73%)

AEONXDIGI

AEONX DIGITAL TECHNOLOGY LIMIT

21474260

+21474146.7 (+18953351.02%)

SHIKHAR

SHIKHAR CONSULTANTS LTD.

972554.2

+972542.95 (+8644826.22%)

PIONEEREMB

PIONEER EMBROIDERIES LTD.

261442.3

+261420.7 (+1210281.02%)

View all

Top gainers

SUNPHARMA

SUN PHARMACEUTICAL IND L

NESTLE INDIA LIMITED

AXIS BANK LIMITED

MAX HEALTHCARE INS LTD

1042.1

+28.00 (+2.76%)

View all

Top losers

ADANIENT

ADANI ENTERPRISES LIMITED

ADANI PORT & SEZ LTD

ITC LTD

BHARTI AIRTEL LIMITED

1811.9

-70.50 (-3.75%)

View all

Frequently asked questions

 As of 31/08/2026, at 15:30 PM, the Indegene Limited share price stands at ₹611.65.

Related tags

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."

**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer

INDEGENE LIMITED Share price

Indegene limited share price today

Indegene Limited stock performance

₹579.85

₹615.5

₹414

₹615.5

Indegene Limited fundamentals

Indegene Limited financials

Particulars

Jun 26 (₹ value in crores)

Revenue

₹340.70

Operating expense

₹294.59

Net income

₹59.90

Net profit margin

17.58%

Earning per share

₹2.49

EBITDA

₹94.10

Effective tax rate

25.12%

Particulars

Mar 26 (₹ value in crores)

Revenue

₹368.20

Operating expense

₹279.10

Net income

₹72.10

Net profit margin

19.58%

Earning per share

₹3.00

EBITDA

₹109.20

Effective tax rate

24.26%

Particulars

Dec 25 (₹ value in crores)

Revenue

₹290.10

Operating expense

₹263.70

Net income

₹34.80

Net profit margin

11.99%

Earning per share

₹1.45

EBITDA

₹60.30

Effective tax rate

28.97%

Particulars

Sep 25 (₹ value in crores)

Revenue

₹306.70

Operating expense

₹246.70

Net income

₹59.90

Net profit margin

19.53%

Earning per share

₹2.50

EBITDA

₹88.10

Effective tax rate

22.7%

Particulars

Jun 25 (₹ value in crores)

Revenue

₹255.60

Operating expense

₹227.89

Net income